Monday - Friday, 6:00 - 7:00 PM ET AstraZeneca CEO Pascal Soriot said artificial intelligence is helping the company develop medicines faster, identify promising drug targets, and improve the odds of ...

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...

Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...

Trying to get medicine approved by the US Food and Drug Administration often feels like buying an expensive lottery ticket, with the uncertain prospect of a reward years away. It takes about a decade ...

Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report on the global effort to find a cure for Alzheimer's. The work is published ...

Eli Lilly LLY1.86%increase; up pointing triangle Chief Executive Dave Ricks was on stage with Nvidia NVDA-1.39%decrease; down pointing triangle founder Jensen Huang earlier this year in San Francisco ...

For more than 50 years, U.S. academic medical centers (AMCs) have been the global engine for pharmaceutical innovation. These university-affiliated hospitals are dedicated to fulfilling the mission ...

AWS has now unveiled Amazon Bio Discovery, an AI platform that grants researchers direct access to a broad library of biological foundation models that can be fine-tuned for specific use cases in drug ...

Insilico Medicine Cayman TopCo’s shares jumped on Monday after it struck an artificial intelligence-driven drug development deal with Eli Lilly & Co. worth up to $2.75 billion. Shares of the Hong Kong ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...